Published in J Am Coll Cardiol on November 15, 1999
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond. Vasc Health Risk Manag (2015) 0.80
Future pharmacologic agents for treatment of heart failure in children. Pediatr Cardiol (2006) 0.78
The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases. Heart Fail Rev (2003) 0.75
Changes in brain natriuretic peptide in chronic heart failure patients treated with long-acting versus short-acting loop diuretics: J-MELODIC subanalysis. Heart Vessels (2017) 0.75
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation (2001) 3.34
Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts. J Am Coll Cardiol (1999) 1.68
Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction. Eur Heart J (1999) 1.67
Sinus node function and ventricular repolarization during exercise stress test in long QT syndrome patients with KvLQT1 and HERG potassium channel defects. J Am Coll Cardiol (1999) 1.59
Repolarization abnormalities detected by magnetocardiography in patients with dilated cardiomyopathy and ventricular arrhythmias. J Cardiovasc Electrophysiol (2001) 1.45
A founder mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease prevalence and molecular diagnostics. J Am Coll Cardiol (2001) 1.39
Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med (2009) 1.35
Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction. J Hypertens (2001) 1.17
Rate adaptation of QT intervals during and after exercise in children with congenital long QT syndrome. Eur Heart J (1998) 1.13
Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart (2006) 1.12
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10
Reversal of autonomic derangements by physical training in chronic heart failure assessed by heart rate variability. Eur Heart J (1995) 1.06
Effect of ethanol drinking, hangover, and exercise on adrenergic activity and heart rate variability in patients with a history of alcohol-induced atrial fibrillation. Am J Cardiol (1998) 1.04
Survey of the coding region of the HERG gene in long QT syndrome reveals six novel mutations and an amino acid polymorphism with possible phenotypic effects. Hum Mutat (2000) 1.02
More light on QT interval measurement. Heart (2002) 1.00
Cellular Fatty Acid profiles of lactobacillus and lactococcus strains in relation to the oleic Acid content of the cultivation medium. Appl Environ Microbiol (1995) 0.99
Homozygosity for a HERG potassium channel mutation causes a severe form of long QT syndrome: identification of an apparent founder mutation in the Finns. J Am Coll Cardiol (2000) 0.98
Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome. J Intern Med (1997) 0.98
Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1. J Am Coll Cardiol (1998) 0.96
The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery by-pass operation. Eur Heart J (1993) 0.96
Response of the QT interval to mental and physical stress in types LQT1 and LQT2 of the long QT syndrome. Heart (2001) 0.95
Magnetocardiographic QT interval dispersion in postmyocardial infarction patients with sustained ventricular tachycardia: validation of automated QT measurements. Pacing Clin Electrophysiol (1998) 0.95
Collagen alterations in chronically sun-damaged human skin. Photochem Photobiol (1993) 0.95
Dispersions of the QT interval in postmyocardial infarction patients presenting with ventricular tachycardia or with ventricular fibrillation. Am J Cardiol (1998) 0.95
Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight. Eur Respir J (2005) 0.94
Multiple forms of sustained monomorphic ventricular tachycardia as common presentation in giant-cell myocarditis. Heart (2007) 0.93
Rabid bat diagnosed in Hawaii. Hawaii Med J (1992) 0.92
Extensive variation in the signal amplitude of the atrial floating VDD pacing electrode. Pacing Clin Electrophysiol (1998) 0.92
Identification of patients with ventricular tachycardia after myocardial infarction by high-resolution magnetocardiography and electrocardiography. J Electrocardiol (1993) 0.89
Postinflammatory elastolysis and cutis laxa: report of a case with aortitis. Pediatr Pathol (1984) 0.89
Persistent ventricular tachycardia resulting in left ventricular dilatation treated with verapamil. Int J Cardiol (1986) 0.86
Transdermal nitrate therapy: bioavailability during exercise increases transiently after the daily change of patch. Br J Clin Pharmacol (1991) 0.86
Itraconazole prevents terfenadine metabolism and increases risk of torsades de pointes ventricular tachycardia. Eur J Clin Pharmacol (1993) 0.85
Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience. Radiology (2000) 0.85
Lung function and radiographic signs of pulmonary fibrosis in oil exposed workers in a cable manufacturing company: a follow up study. Br J Ind Med (1992) 0.85
Molecular genetics of the long QT syndrome: two novel mutations of the KVLQT1 gene and phenotypic expression of the mutant gene in a large kindred. Hum Mutat (1998) 0.84
A critical evaluation of energy expenditure estimates based on individual O2 consumption/heart rate curves and average daily heart rate. Am J Clin Nutr (1983) 0.83
Magnetocardiographic localization of ventricular pre-excitation in a child with a congenital heart defect. Pediatr Cardiol (1995) 0.81
Acute heavy alcohol intake increases silent myocardial ischaemia in patients with stable angina pectoris. Heart (1996) 0.81
Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol (1998) 0.81
Effect of the antimalarial drug halofantrine in the long QT syndrome due to a mutation of the cardiac sodium channel gene SCN5A. Am J Cardiol (2001) 0.81
Non-invasive magnetocardiographic localization of ventricular pre-excitation in the Wolff-Parkinson-White syndrome using a realistic torso model. Eur Heart J (1993) 0.80
Alcohol and sauna bathing: effects on cardiac rhythm, blood pressure, and serum electrolyte and cortisol concentrations. J Intern Med (1992) 0.80
Arrhythmias and ST segment deviation during prolonged exhaustive exercise (ski marathon) in healthy middle-aged men. Eur Heart J (1994) 0.80
Localization of accessory pathways in Wolff-Parkinson-White syndrome by high-resolution magnetocardiographic mapping. J Electrocardiol (1992) 0.79
Heart rate adjustment of magnetic field map rotation in detection of myocardial ischemia in exercise magnetocardiography. Basic Res Cardiol (2002) 0.79
Mutation and enhanced virus transformation of cultured hamster cells by exposure to gaseous ethylene oxide. Environ Mutagen (1986) 0.79
Later potentials on signal-averaged electrocardiograms in children after right ventriculotomy. Pediatr Cardiol (1995) 0.78
Recording locations in multichannel magnetocardiography and body surface potential mapping sensitive for regional exercise-induced myocardial ischemia. Basic Res Cardiol (2001) 0.78
Autonomic modulation of QT intervals in post-myocardial infarction patients with and without ventricular fibrillation. Am J Cardiol (1998) 0.78
Influence of pindolol (Visken) on respiratory function in 20 asthmatic patients. Eur J Clin Pharmacol (1978) 0.78
Comparison of current density viability imaging at rest with FDG-PET in patients after myocardial infarction. Comput Med Imaging Graph (2008) 0.78
Postmyocardial infarction patients susceptible to ventricular tachycardia show increased T wave dispersion independent of delayed ventricular conduction. J Cardiovasc Electrophysiol (2001) 0.78
Current-density estimation of exercise-induced ischemia in patients with multivessel coronary artery disease. J Electrocardiol (2001) 0.78
Higher skeletal muscular metabolic reserve capacity in COPD patients than healthy subjects. Scand J Med Sci Sports (2009) 0.77
Magnetocardiographic intra-QRS fragmentation analysis in the identification of patients with sustained ventricular tachycardia after myocardial infarction. Pacing Clin Electrophysiol (2001) 0.77
Plasma and pericardial fluid natriuretic peptide levels in postinfarction ventricular dysfunction. Eur J Heart Fail (2001) 0.77
Spontaneous variability in the frequency of ventricular premature complexes over prolonged intervals and implications for antiarrhythmic treatment. Am J Cardiol (1987) 0.77
Electrocardiographic assessment of left ventricular hypertrophy with time-voltage QRS and QRST-wave areas. J Hum Hypertens (2004) 0.77
Changes in heart rate variability in elderly patients undergoing major noncardiac surgery under spinal or general anesthesia. Reg Anesth Pain Med (1999) 0.77
Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers. Cardiovasc Drugs Ther (1990) 0.76
A history of stressful life events, prolonged mental stress and arrhythmic events in inherited long QT syndrome. Heart (2010) 0.76
Heart rate variability in diabetic and non-diabetic renal transplant patients. Acta Anaesthesiol Scand (1996) 0.76
Ambulatory ECG recording in patients referred because of syncope or dizziness. Acta Med Scand Suppl (1982) 0.75
The hemodynamic and pharmacokinetic interactions between chronic use of oral levosimendan and digoxin in patients with NYHA Classes II-III heart failure. Int J Clin Pharmacol Ther (2008) 0.75
Synergism in the transformation of hamster embryo cells treated with formaldehyde and adenovirus. Environ Mutagen (1983) 0.75
Electrocardiographic measures of ventricular repolarisation dispersion in patients with coronary artery disease susceptible to ventricular fibrillation. Heart (1998) 0.75
ST-segment level and slope in exercise-induced myocardial ischemia evaluated with body surface potential mapping. Am J Cardiol (2001) 0.75
High-resolution and signal-averaged electrocardiography to separate post-myocardial infarction patients with and without ventricular tachycardia. Eur Heart J (1994) 0.75
[Surgical treatment of Wolff-Parkinson-White syndrome]. Duodecim (1992) 0.75
Pre-implant determinants of adequate long-term function of single lead VDD pacemakers. Europace (2002) 0.75
Father's heart beat responds to the birth of his child. Acta Obstet Gynecol Scand (1995) 0.75
Magnetocardiographic QT dispersion during cardiovascular autonomic function tests. Basic Res Cardiol (2000) 0.75
[Idiopathic ventricular tachycardia]. Duodecim (1996) 0.75
Effects of long-term preservation on growth and productivity of Panax ginseng and Catharanthus roseus cell cultures. Plant Cell Rep (1990) 0.75
Dynamics of the QT interval during and after exercise in healthy children. Eur Heart J (1996) 0.75
Late fields of the magnetocardiographic QRS complex as indicators of propensity to sustained ventricular tachycardia after myocardial infarction. J Cardiovasc Electrophysiol (2000) 0.75
Drug metabolism in canine duodenum. Ann Med Exp Biol Fenn (1973) 0.75
Effects of cardiovascular autonomic function tests on QT dispersion in the 12-lead electrocardiogram of healthy patients. J Electrocardiol (2000) 0.75
Assessment of aortic valve area in aortic stenosis by magnetic resonance imaging. Am J Cardiol (1992) 0.75
[Treating congestive heart failure with pacemaker]. Duodecim (2001) 0.75
Magnetocardiography: supraventricular arrhythmias and preexcitation syndromes. Eur Heart J (1993) 0.75
[To treat a cardiac arrest or to count ventricular arrhythmias?]. Duodecim (1994) 0.75
Linkage of the long QT syndrome to the short arm of chromosome 11: use of five highly polymorphic markers towards more detailed localization of the mutant gene. Hum Genet (1995) 0.75
Beat-to-beat analysis method for magnetocardiographic recordings during interventions. Phys Med Biol (2001) 0.75
Coronary collateral circulation. Clin Cardiol (1991) 0.75
Comparative effects of atenolol-based and amlodipine-based antihypertensive therapy on QT dispersion in hypertensive subjects. J Hum Hypertens (2001) 0.75
[Hereditary polymorphic ventricular tachycardia as a cause of syncopes and sudden cardiac deaths]. Duodecim (2000) 0.75
[Cardiac pacemaker infections in Helsinki University Central Hospital 1989-93]. Duodecim (1994) 0.75
[Atrioventricular junctional ablation as a treatment for atrial fibrillation]. Duodecim (1997) 0.75
[Myocardial sarcoidosis--glucocorticoid management of cardiomyopathy]. Duodecim (1990) 0.75
Work stress and the long QT syndrome: high job strain and effort-reward imbalance at work associated with arrhythmic risk in the long QT syndrome. J Occup Environ Med (2013) 0.75
Magnetocardiographic and electrocardiographic exercise mapping in healthy subjects. Ann Biomed Eng (2001) 0.75
[Electrophysiological evaluation and head-up tilt test for the investigation of unexplained syncope]. Duodecim (1996) 0.75
[Treatment of arrhythmias using catheter ablation]. Duodecim (1992) 0.75
Haemodynamic effects of bopindolol and atenolol in coronary artery disease. A noninvasive study. Ann Med (1990) 0.75
[Arrhythmogenic right ventricular dysplasia and idiopathic tachycardia]. Duodecim (1991) 0.75
Heart rate of physicians participating in the young investigators' award competition. J Intern Med (1992) 0.75